Electronics Manufacturing (EMS)
Contract electronics manufacturing, PLI-driven domestic capacity.
5 stocks 3 drivers led by CPPLUS
PLI Expansion
Production-Linked Incentive scheme expansion across mobiles, semiconductors, auto, pharma, drones, white goods and specialty steel. Cross-cuts EMS, auto ancillaries, pharma and capital goods.
100 /100
Strength · Very High
7-day basket return of 89 member stocks. Real OHLCV.
Stocks
89
Industries
8
Catalysts
5
Stories
7
Related Industries
All Linked Stocks (89)
- ABBOTINDIA.NS secondary
- ACMESOLAR.NS secondary
- ACUTAAS.NS secondary
- ADANIGREEN.NS secondary
- AJANTPHARM.NS secondary
- ALKEM.NS secondary
- AMBER.NS secondary
- ANTHEM.NS secondary
- APOLLOTYRE.NS
- ARE&M.NS
- ASAHIINDIA.NS
- AUROPHARMA.NS secondary
- BALKRISIND.NS
- BDL.NS secondary
- BEL.NS secondary
- BELRISE.NS
- BEML.NS secondary
- BHARATFORG.NS
- BIOCON.NS secondary
- BLUEJET.NS secondary
- BLUESTARCO.NS secondary
- BOSCHLTD.NS
- CAPLIPOINT.NS secondary
- CEATLTD.NS
- CIEINDIA.NS
- CIPLA.NS secondary
- COCHINSHIP.NS secondary
- COHANCE.NS secondary
- CONCORDBIO.NS secondary
- CPPLUS.NS secondary
- CRAFTSMAN.NS
- CROMPTON.NS secondary
- DATAPATTNS.NS secondary
- DIVISLAB.NS secondary
- DIXON.NS secondary
- DRREDDY.NS secondary
- EMCURE.NS secondary
- EMMVEE.NS secondary
- ENDURANCE.NS
- ERIS.NS secondary
- EXIDEIND.NS
- GABRIEL.NS
- GLAND.NS secondary
- GLAXO.NS secondary
- GLENMARK.NS secondary
- GRANULES.NS secondary
- GRSE.NS secondary
- HAL.NS secondary
- HAVELLS.NS secondary
- JBMA.NS
- INDGN.NS secondary
- INOXWIND.NS secondary
- IPCALAB.NS secondary
- IREDA.NS secondary
- JBCHEPHARM.NS secondary
- JKTYRE.NS
- JUBLPHARMA.NS secondary
- KAYNES.NS secondary
- KPRMILL.NS
- LAURUSLABS.NS secondary
Stories Mentioning This Trend
Related Events
⚠️ Educational market context, not investment advice. We are not
SEBI-registered advisors. Everything on this site is descriptive — computed
from price data after market close. Nothing here is a recommendation to buy
or sell any security. Markets carry risk; do your own research.